Objective. Genetic variants in the transcription factor 7-like 2 (TCF7L2) gene have been described as the most noteworthy ones regarding the type 2 diabetes mellitus (T2DM) liability. This work is aimed to evaluate the association between rs12255372 and rs7903146 polymorphisms and T2DM in patients with cardiovascular disease (CAD) risk.
Methods. A sample of six hundred and forty-seven patients that underwent the coronary angiography in a Cardiac Catheterization Lab was evaluated. The patients were investigated for the presence of T2DM and coronary stenosis. The TCF7L2 polymorphisms were genotyped by real-time PCR and the haplotype analysis was performed with the MLOCUS software. All genetic tests were carried out by considering the haplotype combinations in patients divided into three groups: 0 – carrying none disease risk allele, 1 – carrying one or two risk alleles and 2 – carrying three or four risk alleles.
Results. No significant associations between TCF7L2 risk haplotypes and the presence of T2DM or CAD were detected.
Conclusions. Our results indicate that the TCF7L2 rs12255372 and rs7903146 polymorphisms do not influence T2DM in Brazilian patients with the high risk for CAD. Therefore, we assume that these variants may only be relevant for a specific subgroup of T2DM patients or some particular human population.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Ali O. Genetics of type 2 diabetes. World J Diabetes 4114–123 2013.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 36 S67–S74 2013.
Assmann TS Duarte GCK Rheinheimer J Cruz LA Canani LH and Crispim D. The TCF7L2 rs7903146 (C/T) polymorphism is associated with risk to type 2 diabetes mellitus in Southern-Brazil. Arq Bras Endocrinol Metabol 58 918–925 2014.
Barros CMAR Araujo-Neto AP Lopes TR Barros MAL Motta FJN Canalle R Nunes LCC Rey JA Burbano RR Lima-Barros MA Yoshioka FK Pinto GR. Association of the rs7903146 and rs12255372 polymorphisms in the TCF7L2 gene with type 2 diabetes in a population from northeastern Brazil. Genet Mol Res 13 7889–7898 2014.
Bielinski SJ Pankow JS Folsom AR North KE and Boerwinkle E. TCF7L2 single nucleotide polymorphisms cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 51 968–970 2008.
Cauchi S El Achhab Y Choquet H Dina C Krempler F Weitgasser R Nejjari C Patsch W Chikri M Meyre D Froguel P. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 85 777–782 2007.
Chauhan G Spurgeon CJ Tabassum R Bhaskar S Kulkarni SR Mahajan A Chavali S Kumar MV Prakash S Dwivedi OP Ghosh S Yajnik CS Tandon N Bharadwaj D Chandak GR. Impact of common variants of PPARG KCNJ11 TCF7L2 SLC30A8 HHEX CDKN2A IGF2BP2 and CDKAL1 on the risk of type 2 diabetes in 5164 Indians. Diabetes 59 2068–2074 2010.
Dawson K Aflaki M Nattel S. Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing poorly understood area with enormous potential. J Physiol 591 1409–1432 2013.
de Melo SF Frigeri HR dos Santos-Weiss ICR Rea RR de Souza EM Alberton D Gomes de Moraes Rego F Picheth
G. Polymorphisms in FTO and TCF7L2 genes of Euro-Brazilian women with gestational diabetes. Clin Biochem 48 1064–1067 2015.
Grant SF Thorleifsson G Reynisdottir I Benediktsson R Manolescu A Sainz J Helgason A Stefansson H Emilsson V Helgadottir A Styrkarsdottir U Magnusson KP Walters GB Palsdottir E Jonsdottir T Gudmundsdottir T Gylfason A Saemundsdottir J Wilensky RL Reilly MP Rader DJ Bagger Y Christiansen C Gudnason V Sigurdsson G Thorsteinsdottir U Gulcher JR Kong A Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38 320–323 2006.
Jin T. The WNT signalling pathway and diabetes mellitus. Diabetologia 51 1771–1780 2008.
Lahiri DK Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 5444 1991.
Liu Z Habener JF. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem 283 8723–8735 2008.
Long J Edwards T Signorello LB Cai Q Zheng W Shu XO Blot WJ. Evaluation of genome-wide association study-identified type 2 diabetes loci in African Americans. Am J Epidemiol 176 995–1001 2012.
Lyssenko V Lupi R Marchetti P Del Guerra S Orho-Melander M Almgren P Sjogren M Ling C Eriksson KF Lethagen AL Mancarella R Berglund G Tuomi T Nilsson P Del Prato S Groop L. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117 2155–2163 2007.
MacDonald BT Tamai K He X. Wnt/beta-catenin signaling: components mechanisms and diseases. Dev Cell 17 9–26 2009.
Marquezine G Pereira A Sousa A Mill J Hueb W Krieger J. TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association but not a significant tool for risk stratification in the general population. BMC Med Genet 9 106 2008.
Muendlein A Saely CH Geller-Rhomberg S Sonderegger G Rein P Winder T Beer S Vonbank A Drexel H. Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis. PLoS One 6 e17978 2011.
Palsgaard J Emanuelli B Winnay JN Sumara G Karsenty G Kahn CR. Cross-talk between insulin and Wnt signaling in preadipocytes: role of Wnt co-receptor low density lipoprotein receptor-related protein-5 (LRP5). J Biol Chem 287 12016–12026 2012.
Rulifson IC Karnik SK Heiser PW ten Berge D Chen H Gu X Taketo MM Nusse R Hebrok M Kim SK. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci 104 6247–6252 2007.
Schafer SA Tschritter O Machicao F Thamer C Stefan N Gallwitz B Holst JJ Dekker JM ‘t Hart LM Nijpels G van
Haeften TW Haring HU Fritsche A. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50 2443–2450 2007.
Schinner S Ulgen F Papewalis C Schott M Woelk A Vidal-Puig A Scherbaum WA. Regulation of insulin secretion glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules. Diabetologia 51 147–154 2007.
Scott LJ Mohlke KL Bonnycastle LL Willer CJ Li Y Duren WL Erdos MR Stringham HM Chines PS Jackson AU Prokunina-Olsson L Ding CJ Swift AJ Narisu N Hu T Pruim R Xiao R Li XY Conneely KN Riebow NL Sprau AG Tong M White PP Hetrick KN Barnhart MW Bark CW Goldstein JL Watkins L Xiang F Saramies J Buchanan TA Watanabe RM Valle TT Kinnunen L Abecasis GR Pugh EW Doheny KF Bergman RN Tuomilehto J Collins FS Boehnke M. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 1341–1345 2007.
Sousa AGP Marquezine GF Lemos PA Martinez E Lopes N Hueb WA Krieger JE Pereira AC. TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. PLoS One 4 e7697 2009.
Szabo M Mate B Csep K Benedek T. Genetic approaches to the study of gene variants and their impact on the patho-physiology of type 2 diabetes. Biochem Genet 56 22–55 2018.
Tong Y Lin Y Zhang Y Yang J Zhang Y Liu H Zhang B. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 10 15 2009.
Travers ME McCarthy MI. Type 2 diabetes and obesity: genomics and the clinic. Hum Genet 130 41–58 2011.
Turki A Al-Zaben GS Mtiraoui N Marmmuoch H Mahjoub T Almawi WY. Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Tunisian Arab subjects. Gene 513 244–248 2013.
Wang J Zhang J Li L Wang Y Wang Q Zhai Y You H Hu D. Association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus: a meta-analysis. Brazilian J Med Biol Res 46 382–393 2013.
Weedon MN. The importance of TCF7L2. Diabet Med 24 1062–1066 2007.
Xavier HT Izar MC Faria Neto JR Assad MH Rocha VZ Sposito AC Fonseca FA Santos JE dos Santos RD Bertolami MC Faludi AA Martinez TLR Diament J Guimaraes A Forti NA Moriguchi E Chagas ACP Coelho OR Ramires JAF. V Diretriz Brasileira de Dislipidemias e Prevencao da Aterosclerose. Arq Bras Cardiol 101 1–22 2013.